Space Asset Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting financial results for the three and nine months ended September 30, 2026.
VistaGen Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 13, 2026, disclosing a net loss of $23,770 thousand for the six months ended on that date.
Laird Superfood, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 13, 2026, reporting third-quarter net sales of $41,954,481 and total assets of $145,078,640.
American Drive Acquisition Company filed its Form 10-Q for the quarter ended September 30, 2026 with the SEC on November 13, 2026, reporting financial results for the three and nine months ended September 30, 2026.
Ashford Hospitality Trust, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 13, 2026, reporting total revenue of $214,394 thousand for the third quarter and significant gains from property dispositions.
Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen filed an amended beneficial ownership statement with the SEC on November 13, 2026, disclosing their combined holdings in Immatics N.V. ordinary shares as of the event date of September 30, 2026.
AWM Investment Company, Inc. filed Amendment No. 2 to a Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 427,765 shares of SANUWAVE Health, Inc. common stock as of September 30, 2026.
XIB Asset Management Inc. filed a Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 1,700,000 common shares of Sangoma Technologies Corp as of September 30, 2026.
North Run Capital, LP and affiliated reporting persons filed Amendment No. 2 to their Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 3,528,296 shares of TELA Bio, Inc. common stock as of September 30, 2026.
OMERS Administration Corporation filed an amended Schedule 13G on November 13, 2026, disclosing its beneficial ownership of Class B Subordinate Voting Shares of Xanadu Quantum Technologies Limited following a series of share sales and a share class conversion completed by September 30, 2026.